{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:42:41Z","timestamp":1782736961355,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bmcl.2022.128885","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T11:58:12Z","timestamp":1657540692000},"page":"128885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents"],"prefix":"10.1016","volume":"73","author":[{"given":"Yi-Min","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fawad Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-He","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128885_b0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1385272824999200427082108","article-title":"Review: Studies on the synthesis of quinolone derivatives with their antibacterial activity (Part 1)","volume":"24","author":"Kumar","year":"2020","journal-title":"Curr. Org. Chem."},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0010.1","doi-asserted-by":"crossref","unstructured":"(a) Pham TDM, Ziora ZM, Blaskovich MAT. Quinolone antibiotics. Med. Chem. Commun. 2019;10:1719-1739","DOI":"10.1039\/C9MD00120D"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0010.2","doi-asserted-by":"crossref","unstructured":"(b) Mitscher LA. Bacterial topoisomerase inhibitors: Quinolone and pyridone antibacterial agents. Chem. Rev. 2005;105:559-592.","DOI":"10.1021\/cr030101q"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0015.1","doi-asserted-by":"crossref","unstructured":"(a) Chu XM, Wang C, Liu W, et al. Quinoline and quinolone dimers and their biological activities: An overview. Eur. J. Med. Chem. 2019;161:101-117","DOI":"10.1016\/j.ejmech.2018.10.035"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0015.2","doi-asserted-by":"crossref","unstructured":"(b) Zhang TT, Shen WY, Liu ML, et al. Synthesis, antimycobacterial and antibacterial activity of quinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety. Eur. J. Med. Chem. 2015;104:73-85","DOI":"10.1016\/j.ejmech.2015.09.030"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0015.3","doi-asserted-by":"crossref","unstructured":"(c) Xie YP, Sangaraiah N, Meng JP, et al. Unique carbazole-oxadiazole derivatives as new potential antibiotics for combating Gram-positive and -negative bacteria. J. Med. Chem. 2022;65:6171-6190.","DOI":"10.1021\/acs.jmedchem.2c00001"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0020.1","doi-asserted-by":"crossref","unstructured":"(a) Cui SF, Peng LP, Zhang HZ, et al. Novel hybrids of metronidazole and quinolones: Synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin. Eur. J. Med. Chem. 2014;86:318-334","DOI":"10.1016\/j.ejmech.2014.08.063"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0020.2","doi-asserted-by":"crossref","unstructured":"(b) Cui SF, Addla D, Zhou CH. Novel 3\u2011aminothiazolquinolones: Design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism. J. Med. Chem. 2016;59:4488-4510","DOI":"10.1021\/acs.jmedchem.5b01678"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0020.3","doi-asserted-by":"crossref","unstructured":"(c) Cheng Y, Avula SR, Gao WW, et al. Multi-targeting exploration of new 2-aminothiazolyl quinolones: Synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells. Eur. J. Med. Chem. 2016;124:935-945","DOI":"10.1016\/j.ejmech.2016.10.011"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0020.4","doi-asserted-by":"crossref","unstructured":"(d) Gao F, Wang P, Yang H, et al. Recent developments of quinolone-based derivatives and their activities against Escherichia coli. Eur. J. Med. Chem. 2018;157:1223-1248.","DOI":"10.1016\/j.ejmech.2018.08.095"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0025.1","doi-asserted-by":"crossref","unstructured":"(a) Zhang GF, Zhang S, Pan BF, et al. 4-Quinolone derivatives and their activities against Gram positive pathogens. Eur. J. Med. Chem. 2018;143:710-723","DOI":"10.1016\/j.ejmech.2017.11.082"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0025.2","doi-asserted-by":"crossref","unstructured":"(b) Malik M, Mustaev A, Schwanz HA, et al. Nucleic. Acids. Res. 2016;44:3304-3316.","DOI":"10.1093\/nar\/gkw161"},{"key":"10.1016\/j.bmcl.2022.128885_b0030","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","article-title":"Modifications of quinolones and fluoroquinolones: Hybrid compounds and dual-action molecules","volume":"149","author":"Fedorowicz","year":"2018","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.bmcl.2022.128885_b0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0040.1","doi-asserted-by":"crossref","unstructured":"(a) Zhang L, Kumar KV, Geng RX, et al. Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu2+ mediated DNA-targeting antibacterial agents. Bioorg. Med. Chem. Lett. 2015;25:3699-3705","DOI":"10.1016\/j.bmcl.2015.06.041"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0040.2","doi-asserted-by":"crossref","unstructured":"(b) Zhang L, Peng XM, Damu GLV, et al. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med. Res. Rev. 2014;34:340-437.","DOI":"10.1002\/med.21290"},{"key":"10.1016\/j.bmcl.2022.128885_b0045","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bmcl.2022.128885_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113340","article-title":"Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity","volume":"217","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0055.1","doi-asserted-by":"crossref","unstructured":"(a) Zhang L, Addla D, Ponmani J, et al. Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents. Eur. J. Med. Chem. 2016;111:160-182","DOI":"10.1016\/j.ejmech.2016.01.052"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0055.2","doi-asserted-by":"crossref","unstructured":"(b) Zhang L, Kumar KV, Rasheed S, et al. Design, synthesis, and antimicrobial evaluation of novel quinolone imidazoles and interactions with MRSA DNA. Chem. Biol. Drug. Des. 2015;86:648-655","DOI":"10.1111\/cbdd.12532"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0055.3","doi-asserted-by":"crossref","unstructured":"(c) Wang YN, Bheemanaboina RRY, Gao WW, et al. Discovery of benzimidazole-quinolone hybrids as new cleaving agents toward drug-resistant Pseudomonas aeruginosa DNA. ChemMedChem. 2018;13:1004-1017.","DOI":"10.1002\/cmdc.201700739"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0060.1","doi-asserted-by":"crossref","unstructured":"(a) Liu HB, Gao WW, Tangadanchu VKR, et al. Novel aminopyrimidinyl benzimidazoles as potentially antimicrobial agents: Design, synthesis and biological evaluation. Eur. J. Med. Chem. 2018;143: 66-84","DOI":"10.1016\/j.ejmech.2017.11.027"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0060.2","doi-asserted-by":"crossref","unstructured":"(b) Sui YF, Li D, Wang J, et al. Design and biological evaluation of a novel type of potential multi-targeting antimicrobial sulfanilamide hybrids in combination of pyrimidine and azoles. Bioorg. Med. Chem. Lett. 2020;30:126982","DOI":"10.1016\/j.bmcl.2020.126982"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0060.3","doi-asserted-by":"crossref","unstructured":"(c) Zhou Y, Zhang SS, Cai M, et al. Design, synthesis, and antifungal activity of 2,6-dimethyl-4-aminopyrimidine hydrazones as PDHc-E1 inhibitors with a novel binding mode. J. Agric. Food Chem. 2021;69:5804-5817","DOI":"10.1021\/acs.jafc.0c07701"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0060.4","doi-asserted-by":"crossref","unstructured":"(d) Sui YF, Ansari MF, Zhou CH. Pyrimidinetrione-imidazoles as a unique structural type of potential agents towards Candida albicans: Design, synthesis and biological evaluation. Chem. Asian. J. 2021;16:1417-1429.","DOI":"10.1002\/asia.202100146"},{"key":"10.1016\/j.bmcl.2022.128885_b0065","doi-asserted-by":"crossref","first-page":"8930","DOI":"10.1002\/slct.201901924","article-title":"Synthesis and antibacterial evaluation of new pyrimidyl N-ciprofloxacin derivatives","volume":"4","author":"Majid","year":"2019","journal-title":"ChemistrySelect"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0070.1","doi-asserted-by":"crossref","unstructured":"(a) Yang XC, Hu CF, Zhang PL, et al. Coumarin thiazoles as unique structural skeleton of potential antimicrobial agents. Bioorg. Chem. 2022;124:105855","DOI":"10.1016\/j.bioorg.2022.105855"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0070.2","doi-asserted-by":"crossref","unstructured":"(b) Dewangan RP, Verma DP, Verma NK, et al. Spermine-conjugated short proline-rich lipopeptides as broad-spectrum intracellular targeting antibacterial agents. J. Med. Chem. 2022;65:5433-5448.","DOI":"10.1021\/acs.jmedchem.1c01809"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0075.1","doi-asserted-by":"crossref","unstructured":"(a) Yilmaz NK, Schiffer CA. Introduction: Drug resistance. Chem. Rev. 2021;121:3235-3237","DOI":"10.1021\/acs.chemrev.1c00118"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0075.2","doi-asserted-by":"crossref","unstructured":"(b) Varela MF, Stephen J, Lekshmi M, et al. Bacterial resistance to antimicrobial agents. Antibiotics 2021;10:593","DOI":"10.3390\/antibiotics10050593"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0075.3","doi-asserted-by":"crossref","unstructured":"(c) Laxminarayan R. The overlooked pandemic of antimicrobial resistance. The Lancet 2022;399:606-607.","DOI":"10.1016\/S0140-6736(22)00087-3"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0080.1","doi-asserted-by":"crossref","unstructured":"(a) Li HX, Liu JY, Liu CF, et al. Design, synthesis, and biological evaluation of membrane-active bakuchiol derivatives as effective broad-spectrum antibacterial agents. J. Med. Chem. 2021;64:5603-5619","DOI":"10.1021\/acs.jmedchem.0c02059"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0080.2","doi-asserted-by":"crossref","unstructured":"(b) Li FF, Zhao WH, Tangadanchu VKR, et al. Discovery of novel phenylhydrazone-based oxindole-thiolazoles as potent antibacterial agents toward Pseudomonas aeruginosa. Eur. J. Med. Chem. 2022;239:114521.","DOI":"10.1016\/j.ejmech.2022.114521"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0085.1","doi-asserted-by":"crossref","unstructured":"(a) Sui YF, Ansari MF, Fang B, et al. Discovery of novel purinylthiazolylethanone derivatives as anti-Candida albicans. agents through possible multi-faceted mechanisms. Eur. J. Med. Chem. 2021;221:113557","DOI":"10.1016\/j.ejmech.2021.113557"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0085.2","doi-asserted-by":"crossref","unstructured":"(b) Sun H, Huang SY, Jeyakkumar P, et al. Natural berberine-derived azolyl ethanols as new structural antibacterial agents against drug-resistant Escherichia coli. J. Med. Chem. 2022;65:436-459","DOI":"10.1021\/acs.jmedchem.1c01592"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0085.3","doi-asserted-by":"crossref","unstructured":"(c) Liu JY, Li HX, Li HZ, et al. Rational design of dipicolylamine-containing carbazole amphiphiles combined with Zn2+ as potent broad-spectrum antibacterial agents with a membrane-disruptive mechanism. J. Med. Chem. 2021;64:10429-10444","DOI":"10.1021\/acs.jmedchem.1c00858"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0085.4","doi-asserted-by":"crossref","unstructured":"(d) Deng Z, Sun H, Bheemanaboina RRY, et al. Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis. Bioorg. Med. Chem. Lett. 2022;64:128695.","DOI":"10.1016\/j.bmcl.2022.128695"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0090.1","doi-asserted-by":"crossref","unstructured":"(a) Van-Wolferen M, Orell A, Albers SV. Archaeal biofilm formation. Nat. Rev. Microbiol. 2018;16:699-713","DOI":"10.1038\/s41579-018-0058-4"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0090.2","doi-asserted-by":"crossref","unstructured":"(b) Mukherjee M, Cao B. Engineering controllable biofilms for biotechnological applications. Microb. Biotechnol. 2020;14:74-78","DOI":"10.1111\/1751-7915.13715"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0090.3","doi-asserted-by":"crossref","unstructured":"(c) Vishwakarma A, Dang F, Ferrell A, et al. Peptidomimetic polyurethanes inhibit bacterial biofilm formation and disrupt surface established biofilms. J. Am. Chem. Soc. 2021;143:9440-9449.","DOI":"10.1021\/jacs.1c02324"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0095.1","doi-asserted-by":"crossref","unstructured":"(a) Wang J, Ansari MF, Zhou CH. Identification of unique quinazolone thiazoles as novel structural scaffolds for potential Gram-negative bacterial conquerors. J. Med. Chem. 2021;64:7630-7645","DOI":"10.1021\/acs.jmedchem.1c00334"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0095.2","doi-asserted-by":"crossref","unstructured":"(b) Wang J, Zhang PL, Ansari MF, et al. Molecular design and preparation of 2-aminothiazole sulfanilamide oximes as membrane active antibacterial agents for drug resistant Acinetobacter baumannii. Bioorg. Chem. 2021;113:105039","DOI":"10.1016\/j.bioorg.2021.105039"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0095.3","doi-asserted-by":"crossref","unstructured":"(c) Xie YP, Ansari MF, Zhang SL, et al. Novel carbazole-oxadiazoles as potential Staphylococcus aureus germicides. Pestic Biochem Phys. 2021;175:104849","DOI":"10.1016\/j.pestbp.2021.104849"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0095.4","doi-asserted-by":"crossref","unstructured":"(d) Lencova S, Svarcova V, Stiborova H, et al. Bacterial biofilms on polyamide nanofibers: Factors influencing biofilm formation and evaluation. ACS Appl. Mater. Interfaces. 2021;13:2277-2288.","DOI":"10.1021\/acsami.0c19016"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0100.1","doi-asserted-by":"crossref","unstructured":"(a) Zhang HY, Lu QR, Zhang J, et al. Discovery of novel nitrogenous heterocyclic-containing quinoxaline1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages. Eur. J. Med. Chem. 2021;223:113657","DOI":"10.1016\/j.ejmech.2021.113657"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0100.2","doi-asserted-by":"crossref","unstructured":"(b) Mohmmad YW, Aijaz A, Faisal MA, et al. Citral derivative activates cell cycle arrest and apoptosis signaling pathways in Candida albicans by generating oxidative stress. Bioorg. Chem. 2021;115:105260.","DOI":"10.1016\/j.bioorg.2021.105260"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0105.1","doi-asserted-by":"crossref","unstructured":"(a) Yang X, Sun H, Maddili SK, et al. Dihydropyrimidinone imidazoles as unique structural antibacterial agents for drug-resistant gram-negative pathogens. Eur. J. Med. Chem. 2022;232:114188","DOI":"10.1016\/j.ejmech.2022.114188"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0105.2","doi-asserted-by":"crossref","unstructured":"(b) Suresh L, Kumar PSV, Poornachandra Y, et al. Design, synthesis and evaluation of novel pyrazolo-pyrimido[4,5-d]pyrimidine derivatives as potent antibacterial and biofilm inhibitors. Bioorg. Med. Chem. Lett. 2017;27:1451-1457.","DOI":"10.1016\/j.bmcl.2017.01.087"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0110.1","doi-asserted-by":"crossref","unstructured":"(a) Donthiboina K, Anchi P, Gurram S, et al. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Bioorg. Chem. 2020;103:104191","DOI":"10.1016\/j.bioorg.2020.104191"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0110.2","doi-asserted-by":"crossref","unstructured":"(b) Yang XC, Zhang PL, Kumar KV, et al. Discovery of unique thiazolidinone-conjugated coumarins as novel broad spectrum antibacterial agents. Eur. J. Med. Chem. 2022;232:114192","DOI":"10.1016\/j.ejmech.2022.114192"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0110.3","doi-asserted-by":"crossref","unstructured":"(c) Zhang PL, Lavanya G, Zhang SL, et al. An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a. Eur. J. Med. Chem. 2021;229:114050","DOI":"10.1016\/j.ejmech.2021.114050"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0110.4","doi-asserted-by":"crossref","unstructured":"(d) Sun H, Ansari MF, Fang B, et al. Natural berberine-hybridized benzimidazoles as novel unique bactericides against Staphylococcus aureus. J. Agric. Food Chem. 2021;69:7831-7840.","DOI":"10.1021\/acs.jafc.1c02545"},{"key":"10.1016\/j.bmcl.2022.128885_b0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bioorg.2016.08.006","article-title":"An efficient one-pot synthesis of thiochromeno[3,4-d]pyrimidines derivatives: Inducing ROS dependent antibacterial and anti-biofilm activities","volume":"68","author":"Suresh","year":"2016","journal-title":"Bioorg. Chem."},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0120.1","doi-asserted-by":"crossref","unstructured":"(a) Chen XY, Gon\u00e7alves MAFV. DNA, RNA, and protein tools for editing the genetic information in human cells. iScience 2018;6:247-263","DOI":"10.1016\/j.isci.2018.08.001"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0120.2","doi-asserted-by":"crossref","unstructured":"(b) Dong YH, Yao C, Zhu Y, et al. DNA functional materials assembled from branched DNA: Design, synthesis, and applications. Chem. Rev. 2020;120:9420-9481.","DOI":"10.1021\/acs.chemrev.0c00294"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0125.1","doi-asserted-by":"crossref","unstructured":"(a) Hu CF, Zhang PL, Sui YF, et al. Ethylenic conjugated coumarin thiazolidinediones as new efficient antimicrobial modulators against clinical methicillin-resistant Staphylococcus aureus. Bioorg. Chem. 2020;94:103434","DOI":"10.1016\/j.bioorg.2019.103434"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0125.2","doi-asserted-by":"crossref","unstructured":"(b) Xie JY, Zhou M, Qian YX, et al. Addressing MRSA infection and antibacterial resistance with peptoid polymers. Nat. Commun. 2021;12:5898","DOI":"10.1038\/s41467-021-26221-y"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0125.3","doi-asserted-by":"crossref","unstructured":"(c) Wang J, Ansari MF, Lin JM, et al. Design and synthesis of sulfanilamide aminophosphonates as novel antibacterial agents towards Escherichia coli. Chin. J. Chem. 2021;39:2251-2263.","DOI":"10.1002\/cjoc.202100165"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0130.1","doi-asserted-by":"crossref","unstructured":"(a) Wang J, Ansari MF, Zhou CH. Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus. Bioorg. Med. Chem. Lett. 2021;41:127995","DOI":"10.1016\/j.bmcl.2021.127995"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0130.2","doi-asserted-by":"crossref","unstructured":"(b) Kahriman N, Peker K, Serdaro\u011flu V, et al. Novel 2-amino-4-aryl-6-pyridopyrimidines and N-alkyl derivatives: Synthesis, characterization and investigation of anticancer, antibacterial activities and DNA\/BSA binding affinities. Bioorg. Chem. 2020;99:103805","DOI":"10.1016\/j.bioorg.2020.103805"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0130.3","doi-asserted-by":"crossref","unstructured":"(c) Wang LL, Battini N, Bheemanaboina RRY, et al. Design and synthesis of aminothlazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation. Eur. J. Med. Chem. 2019;167:105-123","DOI":"10.1016\/j.ejmech.2019.01.072"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0130.4","doi-asserted-by":"crossref","unstructured":"(d) Wang LL, Battini N, Bheemanaboina RRY, et al. A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV. Eur. J. Med. Chem. 2019;179:166-181.","DOI":"10.1016\/j.ejmech.2019.06.046"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0135.1","doi-asserted-by":"crossref","unstructured":"(a) Wang J, Battini N, Ansari MF, et al. Synthesis and biological evaluation of quinazolonethiazoles as new potential conquerors towards Pseudomonas aeruginosa. Chin. J. Chem. 2021;39:1093-1103","DOI":"10.1002\/cjoc.202000627"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0135.2","doi-asserted-by":"crossref","unstructured":"(b) Zhang GB, Maddili SK, Tangadanchu VKR, et al. Discovery of natural berberine-derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli. Sci. China. Chem. 2018;61:557-568.","DOI":"10.1007\/s11426-017-9169-4"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0140.1","doi-asserted-by":"crossref","unstructured":"(a) Liu J, Gong YL, Shi JT, et al. Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors. Eur. J. Med. Chem. 2020;194:112244","DOI":"10.1016\/j.ejmech.2020.112244"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0140.2","doi-asserted-by":"crossref","unstructured":"(b) Li FF, Zhang PL, Tangadanchu VKR, et al. Novel metronidazole-derived three-component hybrids as promising broad-spectrum agents to combat oppressive bacterial resistance. Bioorg. Chem. 2022;122:105718.","DOI":"10.1016\/j.bioorg.2022.105718"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0145.1","unstructured":"(a) Lapointe G, Skepper CK, Holder LM, et al. Discovery and optimization of dna gyrase and topoisomerase iv inhibitors with potent activity against fluoroquinolone-resistant Gram-positive bacteria. J. Med. Chem. 2021;64:6329-6357"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0145.2","unstructured":"(b) Skepper CK, Armstrong D, Balibar CJ, et al. Topoisomerase inhibitors addressing fluoroquinolone resistance in Gram-negative bacteria. J. Med. Chem. 2020;63:7773-7816."},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0150.1","doi-asserted-by":"crossref","unstructured":"(a) Hatzade KM, Ghatole AM, Gaidhane PK, et al. A facile synthesis of some new pyrimidine-2,4,6-triones analogs and their o-\u03b2-D-glucosides P-glycoprotein and antioxidant, antimicrobial study, blood-brain barrier, cytochrome p450 enzyme activity prediction. Med. Chem. Res. 2021;30:163-181","DOI":"10.1007\/s00044-020-02649-7"},{"key":"#cr-split#-10.1016\/j.bmcl.2022.128885_b0150.2","doi-asserted-by":"crossref","unstructured":"(b) Bo YX, Xiang R, Xu Y, et al. Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors. Bioorg. Med. Chem. 2020;28:115351.","DOI":"10.1016\/j.bmc.2020.115351"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:45:31Z","timestamp":1760773531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22003614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":70,"alternative-id":["S0960894X22003614"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128885","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128885"}}